Literature DB >> 19458906

Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren's syndrome.

Daisuke Wakasugi1, Takashi Kato, Takahisa Gono, Eiichi Ito, Hiroyuki Nodera, Yasushi Kawaguchi, Hisashi Yamanaka, Masako Hara.   

Abstract

Neurological involvement occurs in approximately 20% of patients with primary Sjögren's syndrome. Although neurological symptoms can affect the peripheral nervous system and the central nervous system, the most frequent symptom is polyneuropathy. Small fiber neuropathy (SFN) is a form of painful peripheral polyneuropathy that is common in patients with diabetic neuropathy, but may also occur in toxic, infectious, or immune-mediated neuropathy. We show here a patient with Sjögren's syndrome who developed SFN and was treated with intravenous immunoglobulin (IVIG) therapy, which was immediately and extremely effective. Because of the efficacy of IVIG therapy, we propose that direct immune-mediated mechanisms may be involved in the pathogenesis of SFN complicated by Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458906     DOI: 10.1007/s10165-009-0180-2

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  19 in total

Review 1.  [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 3.  Current Diagnosis and Treatment of Painful Small Fiber Neuropathy.

Authors:  Khosro Farhad
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

4.  Clinical manifestations of neurological involvement in primary Sjögren’s syndrome.

Authors:  Takahisa Gono; Yasushi Kawaguchi; Yasuhiro Katsumata; Kae Takagi; Akiko Tochimoto; Sayumi Baba; Yuko Okamoto; Yuko Ota; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2011-04       Impact factor: 2.980

5.  Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.

Authors:  Lara Heij; Marieke Niesters; Maarten Swartjes; Elske Hoitsma; Marjolein Drent; Ann Dunne; Jan C Grutters; Oscar Vogels; Michael Brines; Anthony Cerami; Albert Dahan
Journal:  Mol Med       Date:  2012-11-15       Impact factor: 6.354

Review 6.  Vasculitis in Sjögren's Syndrome.

Authors:  R Hal Scofield
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

Review 7.  Peripheral neuropathies in rheumatic disease--a guide to diagnosis.

Authors:  Jean-Michel Vallat; Magalie Rabin; Laurent Magy
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

Review 8.  Connective Tissue Disorder-Associated Vasculitis.

Authors:  Aman Sharma; Aadhaar Dhooria; Ashish Aggarwal; Manish Rathi; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

9.  Neurological Complications of Sjögren's Syndrome: Diagnosis and Management.

Authors:  Sara S McCoy; Alan N Baer
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-10-24

10.  Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.

Authors:  Margot Geerts; Bianca T A de Greef; Maurice Sopacua; Sander M J van Kuijk; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Neurology       Date:  2021-03-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.